NIH 2021 R44 HL |
Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing Geisse, Nicholas Andrew / Nanosurface Biomedical, Inc. |
|
NIH 2020 R44 HL |
Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing Geisse, Nicholas Andrew / Nanosurface Biomedical, Inc. |
|
NIH 2019 R44 HL |
Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing Geisse, Nicholas Andrew / Nanosurface Biomedical, Inc. |
|